FDA, CDC Back Boosters For Minors After Conducting Zero Testing On Boosters For Minors

Unsplash
The FDA approved Pfizer Covid booster shots for minors age 16 to 17 years old, yet the FDA conducted ZERO tests in this age bracket before giving their approval. The FDA relied on prior (old) booster data from a study of “200 participants, 18 through 55 years of age.” The booster was approved despite the danger to young males of developing heart problems like myocarditis.

As FDA advisory panelist Dr Eric Rubin said when backing the first round of shots for kids, “We’re never going to learn about how safe this vaccine is unless we start giving it.”

From TechnoFog:

Late last week, on December 9, the FDA approved the Emergency Use Authorization (EUA) for the Pfizer COVID-19 vaccine, “authorizing the use of a single booster dose for administration to individuals 16 and 17 years of age.” The booster is to be given at least 6 months after vaccination.

[…] The Pfizer vaccine is particularly dangerous for young men aged 16-17. As we observed back in October, teenage boys are especially at risk for heart problems – like myocarditis – after getting the Pfizer vaccine:

“Boys between 16 and 19 years of age had the highest incidence of myocarditis after the second dose . . . The risk of heart problems in boys of that age was about nine times higher than in unvaccinated boys of the same age.” – New York Times.

The risk of myocarditis for boys 16 – 19 years old is higher after the Pfizer second dose. What happens after the third dose??

That’s a good question.

One would rightly assume that the third dose might present more danger of heart problems than the second dose. But FDA doesn’t have the answer to this question. And why doesn’t it have the answer?

Because the FDA didn’t look.

Because the FDA conducted ZERO tests in this age bracket before approving the latest Pfizer booster for this age bracket.

Instead, the FDA relied on prior (old) booster data from a study of “200 participants, 18 through 55 years of age.” Choosing to ignore the long-term data for the efficacy of the Pfizer booster shot, the FDA instead reviewed the old data showing “the antibody response against the SARS-CoV-2 virus one month after a booster dose of the vaccine.”

That’s it. That’s the rigorous studies that now meet FDA standards.

Read full article here…

Visit our Classified ads.

Check out our Classified ads at the bottom of this page.

Recent stories & commentary

Classified Ads

The appearance of ads on this site does not signify endorsement by the publisher. We cannot vouch for accuracy of statements or integrity of advertisers. We will investigate complaints, however, and remove any message we find to be misleading or that promotes anything fraudulent or unethical.
For ad rates, click here.

Subscribe
Notify of
guest
1 Comment
Oldest
Newest Most Voted
Inline Feedbacks
View all comments
Questionit21
Questionit21
2 years ago

Was it not in early 2000 that mRNA Gene Therapy were used on Animals and when they were exposed to a Wild Virus they all died. Genocide for all those Animals and now its Genocide to everyone that the Elites will not protect. By the time those who taken the Experimental Gene Therapy inoculations end up in ICU or Died its to late just no one knows which Booster number they take is that it will be Game Over for them. The Health Advisors and Government Corporations and MSM is the Pandemic time to listen to Doctors and Scientists who… Read more »